These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5692400)

  • 1. [Study on beta-glucuronidase activity in infants. 2. Effect of vasopressin on urinary beta-glucuronidase in nephrogenic diabetes insipidus].
    Odawara M
    Nihon Shonika Gakkai Zasshi; 1968 Apr; 72(4):398-409. PubMed ID: 5692400
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of urinary beta-glucuronidase excretion to vasopressin with a possible abnormality in congenital nephrogenic diabetes insipidus.
    Odawara M; Igarashi Y; Yamaguchi K
    Paediatr Univ Tokyo; 1966 Dec; 13():49-53. PubMed ID: 5979955
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies of diabetes insipidus].
    Igarashi Y
    Nihon Naibunpi Gakkai Zasshi; 1966 Dec; 42(9):982-96. PubMed ID: 4291584
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus.
    Jackson BA; Edwards RM; Valtin H; Dousa TP
    J Clin Invest; 1980 Jul; 66(1):110-22. PubMed ID: 6249843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
    Raij K; Perheentupa J; Härkönen M
    Scand J Clin Lab Invest; 1974 Oct; 34(2):177-84. PubMed ID: 4370673
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes insipidus: clinical and basic aspects.
    Majzoub JA; Srivatsa A
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():60-5. PubMed ID: 17261971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiduretic responses to exogenous adenosine 3',5'-monophosphate in man.
    Levine RA
    Clin Sci; 1968 Apr; 34(2):253-60. PubMed ID: 5659819
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrogenic diabetes insipidus: clinical and pathophysiological aspects.
    Niaudet P; Dechaux M; Trivin C; Loirat C; Broyer M
    Adv Nephrol Necker Hosp; 1984; 13():247-60. PubMed ID: 6089520
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of vasopressin on sodium and potassium reabsorption by the renal tubules in man.
    Barraclough M; Guignard J; Jones NF; Knight C; Muirhead-Allwood W; Reid M
    J Physiol; 1969 Jul; 203(1):71P-72P. PubMed ID: 5821919
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
    Dousa TP; Valtin H
    J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic (vasopressin-resistant) diabetes insipidus with the usual X-linked inheritance.
    Bianchine JW; Stambler AA; Harrison HE
    Birth Defects Orig Artic Ser; 1971 May; 7(6):280-1. PubMed ID: 5173179
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules.
    Grantham JJ; Burg MB
    Am J Physiol; 1966 Jul; 211(1):255-9. PubMed ID: 5911047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary nephrogenic diabetes insipidus in the Laurence-Moon-Biedl syndrome (exploration of renal hydric homeostasis)].
    Radice C; D'Amico E; Torti G
    Minerva Pediatr; 1971 Nov; 23(46):1968-73. PubMed ID: 5173396
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes insipidus: etiology, diagnosis, and therapy].
    Laczi F
    Orv Hetil; 2002 Nov; 143(46):2579-85. PubMed ID: 12520852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kidney tubular transport disorders. Nephrogenic diabetes insipidus].
    Ishikawa S
    Nihon Rinsho; 1989 Jul; 47(7):1641-5. PubMed ID: 2530373
    [No Abstract]   [Full Text] [Related]  

  • 17. [NEPHROGENIC DIABETES INSIPIDUS].
    FABIAN J; DUFEK V
    Cas Lek Cesk; 1964 Sep; 103():1078-84. PubMed ID: 14196840
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of antidiuretic hormone on the renal collecting duct.
    Scoble JE; Sweny P; Varghese Z; Moorhead J
    Nephrol Dial Transplant; 1988; 3(1):102-3. PubMed ID: 3132629
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antidiuresis induced by exogenous 3,5-adenosine monophosphate in man].
    Piacentini L; Alberti C; Valentino RV; Santini R
    Minerva Urol; 1969; 21(2):33-40. PubMed ID: 5402678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.